Compare ADMA Biologics Inc (ADMA) vs YieldMax AMZN Option Income Strategy ETF (AMZY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs YieldMax AMZN Option Income Strategy ETF — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while YieldMax AMZN Option Income Strategy ETF trades at $11.5. Which is the better fit depends on your goals.
| ADMA | AMZY | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $20.38 | $15.75 |
52-Week Low | $7.60 | $9.98 |
Enterprise Value | $2.29B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About YieldMax AMZN Option Income Strategy ETF
AMZY is an actively managed ETF that seeks to generate monthly income by selling call options on Amazon (AMZN) stock. It aims to provide high yield while maintaining exposure to the price movements of the e-commerce giant.
Read more on AMZY →
